ESPERITE news, videos and press releases
For more news please use our advanced search feature.
ESPERITE - More news...
ESPERITE - More news...
- Esperite N.V. secures external financing of up to EUR 35 million of convertible notes with warrants drawable under certain conditions
- ESPERITE confirms the investigation on its former subsidiary CryoSave
- ESPERITE N.V. convenes Extraordinary General Meeting of Shareholders on 26 March 2020
- Esperite N.V.: Samples and Database are safe. The recent articles published about CryoSave on loss of samples are poorly informed and defamatory.
- ESPERITE (ESP) is not bankrupt
- Esperite (ESP) disputes the Court verdict and appeals the bankruptcy order.
- Esperite N.V. (ESP) : Update to the market on its Cord Blood Stem Cells Subsidiaries and activity.
- CryoSave has maintained without compromise the high-quality processing and storage services and has handed over its whole business.
- ESPERITE NV AND MYRISOPH CAPITAL CONCLUDE A STRATEGIC AGREEMENT ON CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS
- ESPERITE N.V. (ESP) publishes its half-year report. Revenues, results and consolidated equity were impacted by adverse market conditions on the stem cell business.
- Esperite N.V.: Update to the market on the publication of the Annual Report 2018
- ESPERITE (ESP) announces termination of negotiations regarding proposed sale of stem cell banking business to PBKM
- ESPERITE (ESP) negotiates 18-month extension for EUR 4,750,000 in unsecured convertible loan notes
- ESPERITE (ESP) resumes negotiations regarding proposed sale of stem cell banking business to PBKM
- Esperite NV (ESP) introduces Jouvene - Swiss Medicine Quintessence, the first combined offer of Stem Cell long term storage and highly accurate Whole Genome Sequencing for Consumer distribution.
- Esperite NV (ESP) introduces Jouvene - Swiss Medicine Quintessence, the first combined offer of Stem Cell long term storage and highly accurate Whle Genome Sequencing for Consumer distribution.
- ESPERITE (ESP) announces termination of MoU regarding proposed sale of stem cell banking business to PBKM due to lack of agreement on the terms of the sale
- ESPERITE (ESP) announces listing measure by Euronext due to delay in publication of its 2018 annual report (as announced on 30 April 2019)
- Esperite N.V. (ESP) : Update to the market on the publica-tion of the Annual Report 2018 and The Cell Factory cur-rent configuration.
- Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2018
- ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund
- Esperite N.V. (ESP) with The Cell Factory has confirmed a long-term effect of extracellular vesicle drug candidate CF-MEV-132 for the treatment of Bronchopulmonary Dysplasia.
- ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund
- ESPERITE NV (ESP) AND PBKM (FAMICORD GROUP) SIGN EXCLUSIVE AGREEMENT REGARDING POTENTIAL ACQUISITION OF CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS.
- ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 24th tranche of investment today
- ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 23rd tranche of investment today
- Esperite (ESP) with The Cell Factory, prepares to raise series A round of investments to continue its clinical program testing Extracellular Vesicles drug candidates.
- ESPERITE N.V. convenes Annual General Meeting of Shareholders
- ESPERITE (ESP): financial results for 2017 are published.
- ESPERITE (ESP) announces publication of its Annual Report 2017 before 24 November 2018
